second deriv thesi buy altria
view way expect volum declin get less
bad due easier compar normal ship day cleaner inventori
level wholesal slightli lower drag e-vapor growth add
benefit increment price greater cost save
believ ep growth dramat improv next qs
would buyer mo pull-back
address bear thesi bear thesi mo price power
deterior ultim abl off-set acceler
cigarett industri volum declinestherebi make altria ep
growth unstain call black white either believ
volum growth new normal believ closer
altria suggest base fieldwork believ volum
declin begin moder start due easier compar
normal ship day better match shipment
deplet less drag e-vapor migrat
e-vapor impact moder understand gener
concern impact e-vapor overal cigarett
categori howev believ import distinguish e-
vapor impact cigarett categori impact marlboro
base fieldwork believ actual overlap
marlboro juul e-vapor product limitedwith
brand like newport camel natur american spirit much
interact sens marlboro age consum base
advantag current environ
price hold think differ retail
price altria actual price realiz believ big part altria
price growth due lower level promot spend
compani continu fine-tun retail trade contact per pack
spend level base purchas behavior remind
tobacco industri stop market year ago trade spend
larger industri typic cpg companywhich mean
opportun becom effici also larger addit believ
nation roll-out marlboro reward program addit
data tool help compani becom even effici trade
adjust estim review model detail
rais ep estim vs guidanc rang
due higher price volum assumpt
expect total smokeabl volum price target
unchang current div yield provid downsid support
valu usd unless otherwis note
price prior trade day market close estimate unless otherwis note
capit market appreci consider institut investor all-america research survey
bloomberg capit market estim upside/downside/target
dcf-driven base case altria impli
price-to-earnings assum wacc lt top-lin compound-annual-growth-rate
termin growth rate estim call
cigarett volum declin price
dcf-driven upsid case altria assum
wacc lt top-lin compound-annual-growth-rate termin growth
rate scenario assum cigarett volum
declin low-end rang price
downsid scenario also base dcf
assum revenu compound-annual-growth-rate termin
growth rate primari driver scenario
acceler declin volum fall outsid
assumpt inabl off-set acceler
volum declin price materi slowdown
rate altria share outperform current price mo
share trade price-to-earnings yield
understand make valuat call consum stapl
realli work past year believ
current state overal cpg space make mo attract
place put new money within space compani
essenti hedg three biggest issu face
evolut sell tobacco product ban on-line
rise cost goods/logist make small
percentag cog
rise interest rate fulli acknowledg highlight
risk rate set rise project treasuri
rate rise year-end altria maintain
current yield dividend yield spread versu
would bp year-end
compel level bp benchmark take
account dividend increas altria made
consecut year
competitor product launch success price profil
competitor new product launch import watch
altria result
iqo fda approv roll-out altria manag note
fulli prepar roll iqo market upon
fda approv believ fda approv like howev
expect iqo materi contributor altria top-
line profit howev headlin disappoint around
iqo could spook investor saw upon philip
morri result includ sequenti
deceler iqo drive mo share lower
risk thesi
signific deceler industri volum declin
long-term averag noteworthi innov
e-cigarette/vapor front rise interest rate
deterior tobacco fundament
dcf-driven base case altria impli price-to-earnings assum wacc
lt top-lin compound-annual-growth-rate termin growth rate estim call
cigarett volum declin price price target support
outperform rate
risk rate price target
rise interest rate given tobacco stock often view bond proxi investor
fulli acknowledg highlight risk interest rate expect rise
project treasuri rate rise year-end altria
maintain current yield dividend yield spread versu would
bp year-end compel level bp benchmark take
account dividend increas altria made consecut
deterior tobacco fundament look forward see volum trend normal
back level like closer posit altria suspect abl
realiz consist price past quarter us cigarett industri volum
declin acceler believ follow factor contribut weak
excis tax increas import cigarett consumpt state ca/pa rise ga price
peak condit job lever tobacco consum construct hospit etc
gener lack wage inflat headwind continu would
risk fundament thesi
iqo fda approv roll-out altria manag note fulli prepar roll
iqo market upon fda approv believ fda approv like howev
expect iqo materi contributor altria top-lin profit howev
headlin disappoint around iqo could spook investor saw upon philip
morri result includ sequenti deceler iqo drive
altria group inc engag manufactur sale cigarett smokeless product
wine unit state offer cigarett primarili marlboro brand
smokeless tobacco product copenhagen skoal red seal huski marlboro
snu brand name cigar princip black mild brand pipe tobacco
compani also produc sell blend tabl wine chateau michel
columbia crest name distribut antinori villa maria estat wine champagn
nicola feuillatt unit state addit maintain portfolio leverag
direct financ leas aircraft rail surfac transport electr power real estat
manufactur compani found headquart richmond
ms except ep ratio
sale
net incom common non-gaap
compani report capit market estim
